{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:58:26Z","timestamp":1785578306448,"version":"3.56.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background and Aims:<\/jats:title>\n                    <jats:p>Patients with acetaminophen-induced acute liver failure are more likely to die while on the liver transplant waiting list than those with other causes of acute liver failure. Therefore, there is an urgent need for prognostic biomarkers that can predict the need for liver transplantation early after an acetaminophen overdose.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Approach and Results:<\/jats:title>\n                    <jats:p>\n                      We evaluated the prognostic potential of plasma chemokine C-X-C motif ligand 14 (CXCL14) concentrations in patients with acetaminophen (APAP) overdose (n=50) and found that CXCL14 is significantly higher in nonsurviving patients compared to survivors with acute liver failure (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      &lt; 0.001). Logistic regression and AUROC analyses revealed that CXCL14 outperformed the MELD score, better discriminating between nonsurvivors and survivors. We validated these data in a separate cohort of samples obtained from the Acute Liver Failure Study Group (n = 80), where MELD and CXCL14 had similar AUC (0.778), but CXCL14 demonstrated higher specificity (81.2 vs. 52.6) and positive predictive value (82.4 vs. 65.4) for death or need for liver transplantation. Next, combining the patient cohorts and using a machine learning training\/testing scheme to mimic the clinical scenario, we found that CXCL14 outperformed MELD based on AUC (0.821 vs. 0.787); however, combining MELD and CXCL14 yielded the best AUC (0.860).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>We find in 2 independent cohorts of acetaminophen overdose patients that circulating CXCL14 concentration is a novel early prognostic biomarker for poor outcomes, which may aid in guiding decisions regarding patient management. Moreover, our findings reveal that CXCL14 performs best when measured soon after patient presentation to the clinic, highlighting its importance for early warning of poor prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/hep.0000000000000665","type":"journal-article","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T15:01:33Z","timestamp":1698850893000},"page":"1352-1364","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":22,"title":["The chemokine CXCL14 is a novel early prognostic biomarker for poor outcome in acetaminophen-induced acute liver failure"],"prefix":"10.1097","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5327-9020","authenticated-orcid":false,"given":"David S.","family":"Umbaugh","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4810-4234","authenticated-orcid":false,"given":"Nga T.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2163-9703","authenticated-orcid":false,"given":"Steven C.","family":"Curry","sequence":"additional","affiliation":[{"name":"Department of Medical Toxicology, Banner-University Medical Center Phoenix, Phoenix, Arizona, USA"},{"name":"Department of Medicine, and Division of Clinical Data Analytics and Decision Support, University of Arizona College of Medicine-Phoenix, Phoenix, Arizona, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4019-372X","authenticated-orcid":false,"given":"Jody A.","family":"Rule","sequence":"additional","affiliation":[{"name":"Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2783-5441","authenticated-orcid":false,"given":"William M.","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Digestive and Liver Diseases, University of Texas Southwestern Medical Center, Dallas, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5438-2409","authenticated-orcid":false,"given":"Anup","family":"Ramachandran","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8695-6980","authenticated-orcid":false,"given":"Hartmut","family":"Jaeschke","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City, Kansas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Acute Liver Failure Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,11,1]]},"reference":[{"key":"R1-20260801","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/HEP.0000000000000458","article-title":"Future directions in acute liver failure","volume":"78","author":"Stravitz","year":"2023","journal-title":"Hepatology"},{"key":"R2-20260801","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/hep.20293","article-title":"Acetaminophen and the U.S. Acute Liver Failure Study Group: Lowering the risks of hepatic failure","volume":"40","author":"Lee","year":"2004","journal-title":"Hepatology"},{"key":"R3-20260801","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/lt.24347","article-title":"Determinants of outcome among patients with acute liver failure listed for liver transplantation in the United States","volume":"22","author":"Reddy","year":"2016","journal-title":"Liver Transpl"},{"key":"R4-20260801","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/lt.26563","article-title":"Outcomes of patients with acute liver failure listed for liver transplantation: A multicenter prospective cohort analysis","volume":"29","author":"Karvellas","year":"2023","journal-title":"Liver Transpl"},{"key":"R5-20260801","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/liv.12632","article-title":"Two-year outcomes in initial survivors with acute liver failure: Results from a prospective, multicentre study","volume":"35","author":"Fontana","year":"2015","journal-title":"Liver Int"},{"key":"R6-20260801","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/lt.24403","article-title":"The changing face of liver transplantation for acute liver failure: Assessment of current status and implications for future practice","volume":"22","author":"Donnelly","year":"2016","journal-title":"Liver Transpl"},{"key":"R7-20260801","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/lt.26187","article-title":"Acute liver failure etiology is an independent predictor of waitlist outcome but not posttransplantation survival in a national cohort","volume":"28","author":"Wong","year":"2022","journal-title":"Liver Transpl"},{"key":"R8-20260801","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/lt.26274","article-title":"Acute liver failure on the transplant waiting list: Acetaminophen both better and worse?","volume":"28","author":"Bernal","year":"2022","journal-title":"Liver Transpl"},{"key":"R9-20260801","doi-asserted-by":"crossref","first-page":"724","DOI":"10.7326\/M15-2211","article-title":"Outcomes in adults with acute liver failure between 1998 and 2013: An observational cohort study","volume":"164","author":"Reuben","year":"2016","journal-title":"Ann Intern Med"},{"key":"R10-20260801","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cgh.2015.10.007","article-title":"Ability of King\u2019s College Criteria and Model for End-Stage Liver Disease Scores to predict mortality of patients with acute liver failure: A meta-analysis","volume":"14","author":"McPhail","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R11-20260801","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/hep.510370530","article-title":"Blood lactate as a prognostic marker in acetaminophen-induced acute liver failure","volume":"37","author":"Schmidt","year":"2003","journal-title":"Hepatology"},{"key":"R12-20260801","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/hep.21503","article-title":"MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury","volume":"45","author":"Schmidt","year":"2007","journal-title":"Hepatology"},{"key":"R13-20260801","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.cgh.2016.03.046","article-title":"Development of a model to predict transplant-free survival of patients with acute liver failure","volume":"14","author":"Koch","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R14-20260801","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1053\/j.gastro.2012.07.113","article-title":"Development of an accurate index for predicting outcomes of patients with acute liver failure","volume":"143","author":"Rutherford","year":"2012","journal-title":"Gastroenterology"},{"key":"R15-20260801","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00204-021-03183-0","article-title":"Kupffer cells regulate liver recovery through induction of chemokine receptor CXCR2 on hepatocytes after acetaminophen overdose in mice","volume":"96","author":"Nguyen","year":"2022","journal-title":"Arch Toxicol"},{"key":"R16-20260801","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1084\/jem.194.6.855","article-title":"Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development","volume":"194","author":"Kurth","year":"2001","journal-title":"J Exp Med"},{"key":"R17-20260801","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12950-015-0109-9","article-title":"CXCL14 as an emerging immune and inflammatory modulator","volume":"13","author":"Lu","year":"2016","journal-title":"J Inflamm (Lond)"},{"key":"R18-20260801","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v028.i05","article-title":"Building Predictive Models in R Using the caret Package","volume":"28","author":"Kuhn","year":"2008","journal-title":"J Stat Softw"},{"key":"R19-20260801","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: An open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"R20-20260801","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/bs.apha.2019.01.007","article-title":"Acetaminophen hepatotoxicity: A mitochondrial perspective","volume":"85","author":"Ramachandran","year":"2019","journal-title":"Adv Pharmacol"},{"key":"R21-20260801","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/hep.29802","article-title":"Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort","volume":"69","author":"Church","year":"2019","journal-title":"Hepatology"},{"key":"R22-20260801","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/jalm\/jfac137","article-title":"LDH and the MELD-LDH in severe acute liver injury and acute liver failure: Preliminary confirmation of a novel prognostic score for risk stratification","volume":"8","author":"Price","year":"2023","journal-title":"J Appl Lab Med"},{"key":"R23-20260801","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1016\/j.cgh.2023.03.002","article-title":"The role of carbamoyl phosphate synthetase 1 as a prognostic biomarker in patients with acetaminophen-induced acute liver failure","volume":"21","author":"Kwan","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R24-20260801","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1067\/mcp.2002.121857","article-title":"The value of plasma acetaminophen half-life in antidote-treated acetaminophen overdosage","volume":"71","author":"Schiodt","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"R25-20260801","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1124\/dmd.108.026195","article-title":"Pharmacokinetics of acetaminophen-protein adducts in adults with acetaminophen overdose and acute liver failure","volume":"37","author":"James","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"R26-20260801","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jhep.2019.10.030","article-title":"Early acetaminophen-protein adducts predict hepatotoxicity following overdose (ATOM-5)","volume":"72","author":"Chiew","year":"2020","journal-title":"J Hepatol"},{"key":"R27-20260801","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1002\/cpt.2888","article-title":"Acetaminophen metabolites on presentation following an acute acetaminophen overdose (ATOM-7)","volume":"113","author":"Chiew","year":"2023","journal-title":"Clin Pharmacol Ther"},{"key":"R28-20260801","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1073\/pnas.81.5.1327","article-title":"N-acetyl-p-benzoquinone imine: A cytochrome P-450-mediated oxidation product of acetaminophen","volume":"81","author":"Dahlin","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R29-20260801","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-3565(25)29664-1","article-title":"Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo","volume":"187","author":"Jollow","year":"1973","journal-title":"J Pharmacol Exp Ther"},{"key":"R30-20260801","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0022-3565(25)29663-X","article-title":"Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism","volume":"187","author":"Mitchell","year":"1973","journal-title":"J Pharmacol Exp Ther"},{"key":"R31-20260801","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.toxlet.2020.12.005","article-title":"Mitochondrial protein adduct and superoxide generation are prerequisites for early activation of c-jun N-terminal kinase within the cytosol after an acetaminophen overdose in mice","volume":"338","author":"Nguyen","year":"2021","journal-title":"Toxicol Lett"},{"key":"R32-20260801","doi-asserted-by":"crossref","first-page":"13565","DOI":"10.1074\/jbc.M708916200","article-title":"Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury","volume":"283","author":"Hanawa","year":"2008","journal-title":"J Biol Chem"},{"key":"R33-20260801","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1124\/jpet.105.088898","article-title":"Peroxynitrite-induced mitochondrial and endonuclease-mediated nuclear DNA damage in acetaminophen hepatotoxicity","volume":"315","author":"Cover","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"R34-20260801","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/toxsci\/kfl077","article-title":"Nuclear translocation of endonuclease G and apoptosis-inducing factor during acetaminophen-induced liver cell injury","volume":"94","author":"Bajt","year":"2006","journal-title":"Toxicol Sci"},{"key":"R35-20260801","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/toxsci\/kfab052","article-title":"Spatial reconstruction of the early hepatic transcriptomic landscape after an acetaminophen overdose using single-cell RNA-sequencing","volume":"182","author":"Umbaugh","year":"2021","journal-title":"Toxicol Sci"},{"key":"R36-20260801","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.febslet.2013.04.046","article-title":"CXCL14 is a natural inhibitor of the CXCL12-CXCR4 signaling axis","volume":"587","author":"Tanegashima","year":"2013","journal-title":"FEBS Lett"},{"key":"R37-20260801","doi-asserted-by":"crossref","first-page":"16017","DOI":"10.1038\/npjregenmed.2016.17","article-title":"Cxcl14 depletion accelerates skeletal myogenesis by promoting cell cycle withdrawal","volume":"2","author":"Waldemer-Streyer","year":"2017","journal-title":"NPJ Regen Med"},{"key":"R38-20260801","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1016\/j.febslet.2014.11.009","article-title":"CXCL14 is no direct modulator of CXCR4","volume":"588","author":"Otte","year":"2014","journal-title":"FEBS Lett"},{"key":"R39-20260801","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1096\/fj.201700013R","article-title":"Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4","volume":"31","author":"Collins","year":"2017","journal-title":"FASEB J"},{"key":"R40-20260801","doi-asserted-by":"crossref","first-page":"111240","DOI":"10.1016\/j.fct.2020.111240","article-title":"Mechanisms and pathophysiological significance of sterile inflammation during acetaminophen hepatotoxicity","volume":"138","author":"Jaeschke","year":"2020","journal-title":"Food and Chemical Toxicology"},{"key":"R41-20260801","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00204-023-03478-4","article-title":"Dose-dependent pleiotropic role of neutrophils during acetaminophen-induced liver injury in male and female mice","volume":"97","author":"Nguyen","year":"2023","journal-title":"Arch Toxicol"}],"container-title":["Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/HEP.0000000000000665","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:02:04Z","timestamp":1785574924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/HEP.0000000000000665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/hep.0000000000000665","relation":{},"ISSN":["0270-9139"],"issn-type":[{"value":"0270-9139","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,1]]},"assertion":[{"value":"2023-08-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-10-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}